Background illustration for clinical trials search

Paid Clinical Trials Providence

Discover 489 paid clinical trials in Providence, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

for
Chronic Kidney Disease and Hypertension
Location: East Providence RI, New Bedford MA, Worcester MA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06742723

Phase 3, Recruiting

Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island

for
Breast Cancer, Colorectal Cancer, Covid19
Location: Pawtucket RI
Sponsor: Rhode Island Hospital

Sex: All

Age: 18+

Code: NCT04587258

Recruiting

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

for
End Stage Kidney Disease
Location: East Providence RI, Boston MA, Bloomfield CT,
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT05485961

Phase 2, Phase 3, Recruiting

OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity

for
Vision Loss Night, Vision Disorders
Location: Warwick RI, Woburn MA, Cranberry Township PA, Garner NC,
Sponsor: Opus Genetics, Inc

Sex: All

Age: 18+

Code: NCT07140783

Phase 3, Recruiting

Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: Qualitative Interviews

for
Opioid Use Disorder, Criminal Justice,
Location: Cranston RI
Sponsor: Lifespan

Sex: All

Age: 18+

Code: NCT06354465

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Injectable Buprenorphine in Prison: A Preference Trial

for
Opioid Use Disorder, Incarceration,
Location: Cranston RI
Sponsor: Lifespan

Sex: All

Age: 18+

Code: NCT06880718

Recruiting

Implementing Low-Barrier HCV Treatment in a Jail Setting

for
HEPATITIS C (HCV), Incarceration, Injection Drug Use,
Location: Cranston RI
Sponsor: Lifespan

Sex: All

Age: 18+

Code: NCT06953479

Recruiting

Bucillamine Phase 2 Trial in Patients With Cystinuria

for
Cystinuria
Location: Warwick RI, Boston MA, New York NY, Madison WI,
Sponsor: Revive Therapeutics, Ltd.

Sex: All

Age: 18 - 70+

Code: NCT02942420

Phase 2, Recruiting

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

for
Clonal Mast Cell Disease, KIT D816V Mutation,
Location: Warwick RI, New York NY, Glenn Dale MD, Pittsburgh PA,
Sponsor: Blueprint Medicines Corporation

Sex: All

Age: 18+

Code: NCT07143669

Recruiting

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

for
Atopic Dermatitis
Location: Warwick RI, Portsmouth NH, Falls Church VA,
Sponsor: Sanofi

Sex: All

Age: 12+

Code: NCT07290803

Recruiting

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

for
Locally Advanced Pancreatic Adenocarcinoma
Location: Providence RI, Boston MA, Philadelphia PA,
Sponsor: EXACT Therapeutics AS

Sex: All

Age: 18+

Code: NCT06850623

Phase 2, Recruiting

Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

for
Acute Myeloid Leukemias
Location: Providence RI, Farmington CT, Morristown NJ, Montreal,
Sponsor: Syndax Pharmaceuticals

Sex: All

Age: 12+

Code: NCT07211958

Phase 3, Recruiting

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

for
Type 2 Diabetes
Location: East Greenwich RI, Burke VA, Midlothian VA, Canton OH,
Sponsor: Housey Healthcare ULC

Sex: All

Age: 18+

Code: NCT07546929

Phase 2, Recruiting

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

for
Fibromyalgia
Location: Cranston RI, North Dartmouth MA, Boston MA,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07398417

Phase 3, Recruiting

Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Location: East Greenwich RI, New Bedford MA, Fresno CA, Orange CA,
Sponsor: Altimmune, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07795164

Phase 3, Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Providence RI, Newton MA, Boston MA, Norwich CT,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase 3, Recruiting

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

for
Pediatric Migraine
Location: East Greenwich RI, Cromwell CT, Commack NY, Stamford CT,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04649242

Phase 3, Recruiting

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

for
Acute Treatment of Migraine
Location: East Greenwich RI, Cromwell CT, Commack NY, Stamford CT,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04743141

Phase 3, Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,
Location: East Greenwich RI, Burlington MA, Carmel NY, Albany NY,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18 - 70+

Code: NCT06318169

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis,
Location: East Greenwich RI, Framingham MA, Burlington MA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18 - 70+

Code: NCT06419374

Phase 3, Recruiting